Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2014 - 2026)

Avanos Medical has disclosed Non-Current Deferred Tax Liability across 13 years of filings, most recently posting $5.6 million for Q1 2026.

• Non-Current Deferred Tax Liability for Q1 2026 came in at $5.6 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.6 million (changed 0.0% YoY), and the FY2025 annual result was $6.1 million, up 10.91% from the prior year.
• Non-Current Deferred Tax Liability came in at $5.6 million for Q1 2026 at Avanos Medical, down from $6.1 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $71.1 million in Q4 2022 to a low of $5.5 million in Q4 2024.
• The 5-year median for Non-Current Deferred Tax Liability is $23.6 million (2024), against an average of $22.5 million.
• Across the five-year window, Non-Current Deferred Tax Liability surged 560.71% in 2022 and plunged 76.89% in 2024, its largest moves.
• Avanos Medical's Non-Current Deferred Tax Liability stood at $71.1 million in 2022, then plunged by 66.53% to $23.8 million in 2023, then tumbled by 76.89% to $5.5 million in 2024, then gained by 10.91% to $6.1 million in 2025, then retreated by 8.2% to $5.6 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $5.6 million (Q1 2026), $6.1 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.